While Proteus mirabilis is not a common cause of UTI in the normal host, P. mirabilis causes a high incidence of infection in patients with complicated urinary tracts, i.e., those with functional or anatomic abnormalities or with chronic instrumentation. P. mirabilis expresses a number of proteins, including urease, hemolysin, flagella, fimbriae (four distinct types: MR/P, PMF, ATF, and NAF), amino acid deaminase, and IgA protease, that have been postulated to be virulence factors in urinary tract infection. In our experimental approach, we have identified proteins encoded by the virulence genes, isolated the corresponding gene sequences, constructed specific mutations within these sequences in vitro, introduced these mutations back into the wild type parental strain by allelic exchange, and assessed the contribution to virulence of each specific protein in a mouse model of ascending urinary tact infection. In the current application, we propose to continue our investigation by assessing factors proven to contribute to colonization as well as to analyze newly discovered factors that may play a role in infection. We will then apply these findings towards the development of a vaccine for the prevention of Proteus urinary tract infection.
As specific aims, we propose to: 1. Identify the MR/P fimbrial adhesion that binds to a receptor on kidney epithelial cells; 2. measure in vivo levels of expression of urease, hemolysin, flagella, fimbriae, deaminase, and protease genes during experimental infection; 3. determine the contribution to virulence in a mouse model of ascending UTI of : a. ATF fimbriae, b. NAF fimbriae, c. Amino acid, deaminase, d. IgA protease; 4. determine whether P. mirabilis avoids host defense by flagellar antigenic variation; and 5. initiate development of a vaccine for protection against Proteus UTI and pyelonephritis.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Buckles, Eric L; Luterbach, Courtney L; Wang, Xiaolin et al. (2015) Signature-tagged mutagenesis and co-infection studies demonstrate the importance of P fimbriae in a murine model of urinary tract infection. Pathog Dis 73:
Buckles, Eric L; Wang, Xiaolin; Lane, M Chelsea et al. (2009) Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis 199:1689-97
Lane, M Chelsea; Li, Xin; Pearson, Melanie M et al. (2009) Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli. J Bacteriol 191:1382-92
Zupancic, Margaret L; Frieman, Matthew; Smith, David et al. (2008) Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol Microbiol 68:547-59
Jacobsen, Sandra M; Lane, Mary C; Harro, Jean M et al. (2008) The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. FEMS Immunol Med Microbiol 52:180-93
Ma, Biao; Pan, Shih-Jung; Zupancic, Margaret L et al. (2007) Assimilation of NAD(+) precursors in Candida glabrata. Mol Microbiol 66:14-25
Buckles, Eric L; Wang, Xiaolin; Lockatell, C Virginia et al. (2006) PhoU enhances the ability of extraintestinal pathogenic Escherichia coli strain CFT073 to colonize the murine urinary tract. Microbiology 152:153-60
Castano, Irene; Pan, Shih-Jung; Zupancic, Margaret et al. (2005) Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol Microbiol 55:1246-58
Domergue, Renee; Castano, Irene; De Las Penas, Alejandro et al. (2005) Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308:866-70
Jansen, Angela M; Lockatell, Virginia; Johnson, David E et al. (2004) Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect Immun 72:7294-305

Showing the most recent 10 out of 31 publications